124 related articles for article (PubMed ID: 28100632)
1. The role of hepatic trans-arterial chemoembolization in metastatic medullary thyroid carcinoma: a specialist center experience and review of the literature.
Grozinsky-Glasberg S; Bloom AI; Lev-Cohain N; Klimov A; Besiso H; Gross DJ
Eur J Endocrinol; 2017 Apr; 176(4):463-470. PubMed ID: 28100632
[TBL] [Abstract][Full Text] [Related]
2. Hepatic intra-arterial therapies in metastatic neuroendocrine tumors: lessons from clinical practice.
Grozinsky-Glasberg S; Kaltsas G; Kaltsatou M; Lev-Cohain N; Klimov A; Vergadis V; Uri I; Bloom AI; Gross DJ
Endocrine; 2018 Jun; 60(3):499-509. PubMed ID: 29383678
[TBL] [Abstract][Full Text] [Related]
3. Extrahepatic disease should not preclude transarterial chemoembolization for metastatic neuroendocrine carcinoma.
Arrese D; McNally ME; Chokshi R; Feria-Arias E; Schmidt C; Klemanski D; Gregory G; Khabiri H; Shah M; Bloomston M
Ann Surg Oncol; 2013 Apr; 20(4):1114-20. PubMed ID: 23456380
[TBL] [Abstract][Full Text] [Related]
4. Chemoembolization for liver metastases from medullary thyroid carcinoma.
Fromigué J; De Baere T; Baudin E; Dromain C; Leboulleux S; Schlumberger M
J Clin Endocrinol Metab; 2006 Jul; 91(7):2496-9. PubMed ID: 16608897
[TBL] [Abstract][Full Text] [Related]
5. An Overview of Medullary Thyroid Cancer Cases Treated at Kuwait Cancer Control Center.
Shete J; AlSaleh K; Safwat R; Bedair A; ElSherify M; Hussein A; Nazeeh M; Mohanty A
Gulf J Oncolog; 2020 Sep; 1(34):39-47. PubMed ID: 33431361
[TBL] [Abstract][Full Text] [Related]
6. Structural Doubling Time Predicts Overall Survival in Patients with Medullary Thyroid Cancer in Patients with Rapidly Progressive Metastatic Medullary Thyroid Cancer Treated with Molecular Targeted Therapies.
Yeh T; Yeung M; Sherman EJ; Tuttle RM; Sabra MM
Thyroid; 2020 Aug; 30(8):1112-1119. PubMed ID: 32131709
[No Abstract] [Full Text] [Related]
7. Interventional Radiology Approaches for Liver Metastases from Thyroid Cancer: A Case Series and Overview of the Literature.
Nervo A; Ragni A; Retta F; Calandri M; Gazzera C; Gallo M; Piovesan A; Arvat E
J Gastrointest Cancer; 2021 Sep; 52(3):823-832. PubMed ID: 33999355
[TBL] [Abstract][Full Text] [Related]
8. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR
Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207
[TBL] [Abstract][Full Text] [Related]
9. Selective arterial chemoembolization for hepatic metastases from medullary thyroid carcinoma.
Lorenz K; Brauckhoff M; Behrmann C; Sekulla C; Ukkat J; Brauckhoff K; Gimm O; Dralle H
Surgery; 2005 Dec; 138(6):986-93; discussion 993. PubMed ID: 16360382
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis and treatment of primary hepatic neuroendocrine carcinoma].
Xu K; Chen Y; Chen M; Zhang W; Wang Y; Ji W; Wang H; Xin X; Feng J; Li Y; Yan L
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):451-5. PubMed ID: 26463150
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine hepatic metastases: does aggressive management improve survival?
Touzios JG; Kiely JM; Pitt SC; Rilling WS; Quebbeman EJ; Wilson SD; Pitt HA
Ann Surg; 2005 May; 241(5):776-83; discussion 783-5. PubMed ID: 15849513
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.
Ito Y; Onoda N; Ito KI; Sugitani I; Takahashi S; Yamaguchi I; Kabu K; Tsukada K
Thyroid; 2017 Sep; 27(9):1142-1148. PubMed ID: 28635560
[TBL] [Abstract][Full Text] [Related]
13. Bone Metastases in Medullary Thyroid Carcinoma: High Morbidity and Poor Prognosis Associated With Osteolytic Morphology.
Vogel T; Wendler J; Frank-Raue K; Kreissl MC; Spitzweg C; Fassnacht M; Raue F; Kroiss M
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32072159
[TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period.
Gruber-Rouh T; Naguib NN; Eichler K; Ackermann H; Zangos S; Trojan J; Beeres M; Harth M; Schulz B; Nour-Eldin A NE; Vogl TJ
Int J Cancer; 2014 Mar; 134(5):1225-31. PubMed ID: 23960002
[TBL] [Abstract][Full Text] [Related]
15. [Transarterial chemoembolization of liver metastases of colorectal carcinoma using degradable starch microspheres (Spherex): personal investigations and review of the literature].
Wasser K; Giebel F; Fischbach R; Tesch H; Landwehr P
Radiologe; 2005 Jul; 45(7):633-43. PubMed ID: 15316615
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer.
Sun JH; Zhou TY; Zhang YL; Zhou GH; Nie CH; Zhu TY; Chen SQ; Wang BQ; Ye S; Shen Y; Guo H; Wang WL; Zheng SS
Oncotarget; 2017 Jun; 8(24):39746-39755. PubMed ID: 28099930
[TBL] [Abstract][Full Text] [Related]
17. Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results.
de Baere T; Deschamps F; Teriitheau C; Rao P; Conengrapht K; Schlumberger M; Leboulleux S; Baudin E; Hechellhammer L
J Vasc Interv Radiol; 2008 Jun; 19(6):855-61. PubMed ID: 18503899
[TBL] [Abstract][Full Text] [Related]
18. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
19. Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead®, drug-eluting bead loaded with irinotecan: results of a phase II clinical study.
Aliberti C; Fiorentini G; Muzzio PC; Pomerri F; Tilli M; Dallara S; Benea G
Anticancer Res; 2011 Dec; 31(12):4581-7. PubMed ID: 22199334
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant TACE before laser induced thermotherapy (LITT) in the treatment of non-colorectal non-breast cancer liver metastases: feasibility and survival rates.
Vogl TJ; Kreutzträger M; Gruber-Rouh T; Eichler K; Nour-Eldin NE; Zangos S; Naguib NN
Eur J Radiol; 2014 Oct; 83(10):1804-10. PubMed ID: 25082479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]